In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine

Magnetic Resonance in Medicine

Volumn 74, Issue 6, 2015, Pages 1530-1542

  Xu, Su ^a   Waddell, Jaylyn ^a   Zhu, Wenjun ^a   Shi, Da ^a   Marshall, Andrew D ^a   McKenna, Mary C ^a   Gullapalli, Rao P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

in vivo proton magnetic resonance spectroscopy; neonatal hypoxic ischemic rat brain injury; neuroprotection effect of acetyl L carnitine

Indexed keywords

AMINO ACIDS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROTONS; RAT CONTROL; SPECTROSCOPIC ANALYSIS;

CONTROL GROUPS; HYPOXIA-ISCHEMIA; IN-VIVO; L-CARNITINE; NEUROPROTECTIVE EFFECTS; POINT RESOLVED SPECTROSCOPY METHODS; RAT BRAIN; SPRAGUE-DAWLEY RATS;

RATS;

CREATINE; GLUTATHIONE; INOSITOL; LACTIC ACID; LEVACECARNINE; TAURINE; ACETYLCARNITINE; NEUROPROTECTIVE AGENT;

ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENERGY YIELD; FEMALE; HIPPOCAMPUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; PUP (RODENT); RAT; SPRAGUE DAWLEY RAT; ANIMAL; DRUG MONITORING; HUMAN; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN, DISEASES; METABOLISM; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACETYLCARNITINE; ANIMALS; CREATINE; DRUG MONITORING; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INJECTIONS, SUBCUTANEOUS; LONGITUDINAL STUDIES; MALE; NEUROPROTECTIVE AGENTS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84955216091     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25537     Document Type: Article

References (102)

1. Shankaran S,. Neonatal encephalopathy: treatment with hypothermia. J Neurotrauma 2009; 26: 437-443.
2. Robertson CM, Finer NN, Grace MG,. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr 1989; 114: 753-760.
3. Vannucci RC, Perlman JM,. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1997; 100: 1004-1014.
4. Badawi N, Felix JF, Kurinczuk JJ, Dixon G, Watson L, Keogh JM, Valentine J, Stanley FJ,. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol 2005; 47: 293-298.
5. Ambalavanan N, Carlo WA, Shankaran S, et al., Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy. Pediatrics 2006; 118: 2084-2093.
6. Perlman M, Shah PS,. Hypoxic-ischemic encephalopathy: challenges in outcome and prediction. J Pediatr 2011; 158 (Suppl.): e51-e54.
7. Vannucci RC,. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1990; 85: 961-968.
8. Whitelaw A,. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin Neonatol 2000; 5: 33-40.
9. Goñi-de-Cerio F, Lara-Celador I, Alvarez A, Hilario E,. Neuroprotective therapies after perinatal hypoxic-ischemic brain injury. Brain Sci 2013; 3: 191-214.
10. Chicha L, Smith T, Guzman R,. Stem cells for brain repair in neonatal hypoxia-ischemia. Child Nerv Syst 2014; 30: 37-46.
11. Compagnoni G, Pogliani L, Lista G, Castoldi F, Fontana P, Mosca F,. Hypothermia reduces neurological damage in asphyxiated newborn infants. Biol Neonate 2002; 82: 222-227.
12. Thoresen M, Whitelaw A,. Therapeutic hypothermia for hypoxic-ischaemic encephalopathy in the newborn infant. Curr Opin Neurol 2005; 18: 111-116.
13. Shah PS, Ohlsson A,., Perlman M,. Hypothermia to treat neonatal hypoxic ischemic encephalopathy: a systemic review. Arch Pediatr Adolesc Med 2007; 161: 951-958.
14. Robertson CL,. Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals. J Bioenerg Biomembr 2004; 36: 363-368.
15. Vannucci RC, Connor JR, Mauger DT, Paimer C, Smith MB, Towfighi J, Vannucci SJ,. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 1999; 55: 158-163.
16. Xu S, Chuo J, Shi D, Roys S, Fiskum G, Gullapalli R,. Early Microstructural and Metabolic Changes Following Controlled Cortical Impact Injury in rat: a magnetic resonance imaging and spectroscopy study. J Neurotrauma 2011; 28: 2091-2102.
17. Dubowitz LM, Bydder GM,. Nuclear magnetic resonance imaging in the diagnosis and follow-up of neonatal cerebral injury. Clin Perinatol 1985; 12: 243-260.
18. Peden CJ, Rutherford MA, Sargentoni J, Cox IJ, Bryant DJ, Dubowitz LMS,. Proton spectroscopy of the neonatal brain following hypoxic-ischaemic injury. Dev Med Child Neurol 1993; 35: 502-510.
19. Hanrahan JD, Sargentoni J, Azzopardi D, Manji K, Cowan FM, Rutherford MA, Cox IJ, Bell JD, Bryant DJ, Edward AD,. Cerebral metabolism within 18 h of birth asphyxia: a proton magnetic resonance spectroscopy study. Pediatr Res 1996; 39: 584-590.
20. Penrice J, Cady EB, Lorek A, Wylezinska M, Amess PN, Aldridge RF, Stewart AL, Wyatt JS, Reynold EOR,. Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes following perinatal hypoxiaischaemia. Pediatr Res 1996; 40: 6-14.
21. Cady EB,. Metabolite concentrationsand relaxation in perinatal cerebral hypoxic-ischaemic injury. Neurochem Res 1996; 21: 1043-1052.
22. Cady EB,. Magnetic resonance spectroscopy in neonatal hypoxic-ischaemic insults. Child Nerv Syst 2001; 17: 145-149.
23. Holshouser SA, Ashwal S, Luh GY, Shu S, Kahlon S, Auld KL, Tomasi LG, Perkin RM, Hinshaw DB Jr,. Proton spectroscopy after acute central nervous system injury; outcome prediction in neonates, infants, and children. Radiology 1997; 202: 487-496.
24. Barkovich AJ, Baranski K, Vigneron D, Partridge JC, Hallam DK, Hajnal BL, Ferriero DM,. Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates. AJNR Am J Neuroradiol 1999; 20: 1399-1405.
25. Amess PN, Penrice J, Wylezinska M, Lorek A, Townsend J, Wyatt JS, Amiel-Tison C, Cady EB, Stewart A,. Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injury. Dev Med Child Neurol 1999; 41: 436-445.
26. Robertson NJ, Lewis RH, Cowan FM, Allsop JM, Counsell SJ, Edward AD, Cox IJ,. Early increases in brain myo-inosotol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr Res 2001; 50: 692-700.
27. Groenendaal F, Roelants-van Rijn AM, van der Grond J, Toet MC, de Vries LS,. Glutamate in cerebral tissue of asphyxiated neonates during the first week of life demonstrated in vivo using proton magnetic resonance spectroscopy. Biol Neonate 2001; 79: 254-257.
28. Fan G, Wu Z, Chen L, Guo Q, Ye B, Mao J,. Hypoxic-ischemic encephalopathy in full-term neonate: correlation of proton MR spectroscopy with MR imaging. Eur J Radiol 2003; 45: 91-98.
29. Cheong JL, Cady EB, Penrice J, Wyatt JS, Cox IJ,., Robertson NJ,. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am J Neuroradiol 2006; 27: 1546-1554.
30. Boichot C, Walker PM, Durand C, Grimaldi M, Chapuis S, Gouyon JB, Brunotte F,. Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology 2006; 239: 839-848.
31. Shanmugalingam S, Thornton JS, Iwata O, Priest AN, Ordidge RJ, Cady EB, Wyatt JS, Robertson NJ,. Comparative prognostic utilities of early quantitative magnetic resonance imaging spin-spin relaxometry and proton magnetic resonance spectroscopy in neonatal encephalopathy. Pediatrics 2006; 118: 1467-1477.
32. Zhu W, Zhong W, Qi J, Yin P, Wang C, Chang L,. Proton magnetic resonance spectroscopy in neonates with hypoxicischemic injury and its prognostic value. Transl Res 2008; 152: 225-232.
33. Thayyil S, Chandrasakaran M, Taylor A, Bainbridge A, Cady EB, Chong WK, Murad S, Omar RZ, Robertson NJ,. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 2010; 125: e382-e395.
34. van Doormaal PJ, Meiners LC, ter Horst HJ, van der Veere CN, Sijens PE,. The prognostic value of multivoxel magnetic resonance spectroscopy determined metabolite levels in white and grey matter brain tissue for adverse outcome in term newborns following perinatal asphyxia. Eur Radiol 2011; 22: 772-778.
35. 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci U S A 1983; 80: 4945-4948.
36. Malisza KL, Kozlowski P, Ning G, Bascaramurty S, Tuor UI,. Metabolite changes in neonatal rat brain during and after cerebral hypoxia-ischemia: a magnetic resonance spectroscopic imaging study. NMR Biomed 1999; 12: 31-38.
37. 1H-MRS and MRI. Magn Reson Imaging 2004; 22: 457-465.
38. Arenas J, Rubio JC, Martin MA, Campos Y,. Biological roles of L-carnitine in perinatal metabolism. Early Hum Dev 1998; 53: S43-S50.
39. Onofrj M, Ciccocioppo F, Varanese S, di Muzio A, Calvani M, Chiechio S, Osio M, Thomas A,. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert Rev Neurother 2013; 13: 925-936.
40. Scafidi S, Fiskum G, Lindauer SL, Bamford P, Shi D, Hopkins I, McKenna MC,. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem 2010; 114: 820-831.
41. Zanelli SA, Solenski NJ, Rosenthal RE, Fiskum G,. Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. Ann N Y Acad Sci 2005; 1053: 153-161.
42. Liu Y, Rosenthal RE, Starke-Reed P, Fiskum G,. Inhibition of post-cardiac arrest brain protein oxidation by acetyl-L-carnitine. Free Radic Biol Med 1993; 15: 667-670.
43. Bogaert YE, Rosenthal RE, Fiskum G,. Post-ischemic inhibition of cerebralcortex pyruvate dehydrogenase. Free Radic Biol Med 1994; 6: 811-820.
44. Colucci WJ, Gandour RD,. Carnitine acyltransferase: a review of its biology, enzymology and bioorganic chemistry. Bioorg Chem 1988; 16: 307-334.
45. Bremer J,. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 1990; 28: 297-301.
46. Chiechio S, Copani A, De Petris L, Morales ME, Nicoletti F, Gereau RW IV,. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of l-acetylcarnitine. Mol Pain 2006; 2: 20.
47. Coran AG, Drongowski RA, Baker PJ,. The metabolic effects of oral L-carnitine administration in infants receiving total parenteral nutrition with fat. J Pediatr Surg 1985; 20: 758-764.
48. Wainwright MS, Mannix MK, Brown J, Stumpf DA,. L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats. Pediatr Res 2003; 54: 688-695.
49. Scafidi S, Racz J, Hazelton J, McKenna MC, Fiskum G,. Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Dev Neurosci 2010; 32: 480-487.
50. Rice JE III, Vannucci RC, Brierley JB,. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141.
51. Frahm J, Haase A, Matthaei D,. Rapid NMR imaging of dynamic processes using the FLASH technique. Magn Reson Med 1996; 3: 321-327.
52. Haase A, Frahm J, Matthaei D, Hänicke W, Merboldt KD,. FLASH imaging: rapid NMR imaging using low flip angle pulses. J Magn Reson 1986; 67: 258-266.
53. Gruetter R,. Automatic, localized in vivo adjustment of the first- and second-order shim coils. Magn Reson Med 1993; 29: 804-811.
54. 1H MR spectroscopy in the awake rat brain at 7 T. Magn Reson Med 2012; 69: 937-943.
55. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
56. 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264.
57. 1H MRS of rat forebrain from infancy to adulthood reveals adolescence as a distinctive phase of neurometabolite development. NMR Biomed 2013; 26: 683-691.
58. Harris JL, Yeh HW, Choi IY, Lee P, Berman NE, Swerdlow RH, Craciunas SC, Brooks WM,. Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms. J Cereb Blood Flow Metab 2012; 32: 2122-2134.
59. 1H NMR spectroscopy. Magn Reson Med 2003; 50: 24-32.
60. Toga AW, Thompson PM,. Mapping brain asymmetry. Nat Rev Neurosci 2003; 4: 37-48.
61. Diamond MC, Murphy GM Jr, Akiyama K, Johnson RE,. Morphologic hippocampal asymmetry in male and female rats. Exp Neurol 1982; 76: 553-565.
62. Diamond MC, Johnson RE, Young D, Singh SS,. Age-related morphologic differences in the rat cerebral cortex and hippocampus: male-female; right-left. Exp Neurol 1983; 81: 1-13.
63. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM,. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007; 81: 89-131.
64. Halliwell B,. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
65. Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA,. Glutathione peroxidasecatalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 2004; 24: 1531-1540.
66. Ferriero DM,. Neonatal brain injury. N Engl J Med 2004; 351: 1985-1995.
67. Janáky R, Cruz-Aguado R, Oja SS, Shaw CA,. 2007. Glutathione in the nervous system: roles in neural function and health and implications for neurological disease. In:, Lajtha A, Baker G, Dunn S, Holt A, editors. Handbook of neurochemistry and molecular neurobiology. New York: Springer; 2007. p 347-399.
68. McKenna M, Dienel GA, Sonnewald U, Waagepetersen H, Schousboe A,. 2012. Energy metabolism of the brain. In:, Brady ST, editor. Basic neurochemistry: principles of molecular, cellular and medical neurobiology. 8th edition. New York: Elsevier Inc; 2012. p 200-231.
69. Warner D, Sheng H, Batinic-Haberle I,. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004; 207: 3221-3231.
70. Love S,. Oxidative stress in brain ischemia. Brain Pathol 1990; 9: 119-131.
71. Jain A, Martensson J, Stole E, Auld PAM, Meister A,. Glutathione deficiency lead to mitochondrial damage in brain. Proc Natl Acad Sci U S A 1991; 88: 1913-1917.
72. Mizui T, Kinouchi H, Chan PH,. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol 1992; 262: H313-H317.
73. Eppler B, Dawson R Jr,. Dietary taurine manipulations in aged male Fischer 344 rat tissue: taurine concentration, taurine biosynthesis, and oxidative markers. Biochem Pharmacol 2001; 62: 29-39.
74. Lima L, Obregõn F, Roussõ T, Quintal M, Benzo Z, Auladell C,. Content and concentration of taurine, hypotaurine, and zinc in the retina, the hippocampus, and the dentate gyrus of the rat at various postnatal days. Neurochem Res 2004; 29: 247-255.
75. 1H NMR spectroscopy at 14.1 T and the effect of recurrent anaesthesia. J Neurochem 2010; 115: 1466-1477.
76. Chen TS, Richie JP Jr, Lang CA,. The effect of aging on glutathione and cysteine levels in different regions of the mouse brain. Proc Soc Exp Biol Med 1989; 190: 399-402.
77. Stipanuk MH, Coloso RM, Garcia RAG, Banks MF,. Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocytes. J Nutr 1992; 122: 420-427.
78. El Idrissi A, Trenkner E,. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 1999; 921: 9459-9468.
79. El Idrissi A, Trenkner E,. Taurine regulates mitochondrial calcium homeostasis. Adv Exp Med Biol 2003; 526: 527-536.
80. Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ, Hu CC, Faiman MD, Schloss JV, Wu JY,. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J Neurosci Res 2001; 66: 612-619.
81. Wu H, Jin Y, Wei J, Jin H, Sha D, Wu JY,. Mode of action of taurine as a neuroprotector. Brain Res 2005; 1038: 123-131.
82. Chan CY, Sun H, Shah SM, Agovic MS, Friedman E, Banerjee SP,. Modes of direct modulation by taurine of the glutamate NMDA receptor in rat cortex. Eur J Pharmacol 2014; 728: 167-175.
83. Mujsce DJ, Christensen MA, Vannucci RC,. Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage. Pediatr Res 1990; 27: 450-453.
84. Risher WC, Andrew RD, Kirov SA,. Real-time passive volume responses of astrocytes to acute osmotic and ischemic stress in cortical slices and in vivo revealed by two-photon microscopy. Glia 2009; 57: 207-221.
85. Solia JM, Herranz AS, Herreras O, Lerma J, Del Rio RM,. Does taurine act as an osmoregulatory substance in the rat brain. Neurosci Lett 1988; 91: 53-58.
86. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdernik TL,. A possible role for taurine in osmoregulation within the brain. J Neurochem 1988; 51: 740-745.
87. Schaffer S, Takahashi K, Azuma J,. Role of osmoregulation in the actions of taurine. Amino Acid 2000; 19: 527-546.
88. Thurston JH, Sherman WR, Hauhart RE, Kloepper RF,. myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 1989; 26: 482-485.
89. Vitvitsky V, Garg SK, Banerjee R,. Taurine biosynthesis by neurons and astrocytes. J Biol Chem 2011; 37: 32002-32110.
90. 1H magnetic resonance spectra. Neurochem Res 2014; 39: 1-36.
91. Davies SE, Gotoh M, Richard DA, Obrenovitch TP,. 1998. Hypoosmolarity induces an increase of extracellular Nacetylaspartate concentration in the rat striatum. Neurochem Res 1998; 23: 1021-1025.
92. Lohr JW, McReynold J, Grimaldi T, Acara M,. Effect of acute and chronic hypernatremia on myo-inositol and sorbitol concentration in rat brain and kidney. Life Sci 1988; 43: 271-276.
93. Dombrowski GJ Jr, Swiatek KR, Chao KL,. Lactate, 3-hydroxybutyrate, and glucose as substrates for the early postnatal rat brain. Neurochem Res 1989; 14: 667-475.
94. Pellerin L, Pellegri G, Martin JL, Magistretti PJ,. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs adult brain. Proc Natl Acad Sci U S A 1998; 95: 3990-3995.
95. Wallimann T, Tokarska-Schlattner M, Schlattner U,. The creatine kinase system and pleiotropic effects of creatine. Amino Acid 2001; 40: 1271-1296.
96. Urenjak J, Williams SR, Gadian DG, Noble M,. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neuralcell types. J Neurosci 1993; 13: 981-989.
97. Kreis R, Ernst T, Ross BD,. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424-437.
98. Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R,. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 2009; 9: 39.
99. Fiskum G, Liu Y, Bogaert YE, Rosenthal RE, Krieglstein J, Oberpichler-Schwenk H,. Acetyl-l-carnitine stimulates cerebral oxidative metabolism and inhibits protein oxidation following cardiac arrest in dogs. In:, Krieglstein J, editor. Pharmacology of cerebral ischemia. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1992. p 487-491.
100. Calabrese V, Ravagna A, Colombrita C, Scapagnini G, Guagliano E, Calvani M, Butterfield DA, Guiffrida Stella AM,. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res 2005; 79: 509-521.
101. Rosenthal RE, Williams R, Bogaert YE, Getson PR, Fiskum G, Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke 1992; 23: 1312-1317.
102. Winter BK, Fiskum G, Gallo LL,. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995; 72: 1173-1179.